VRTX has another record. FDA approve drug in 3 month. Unbelievable. Normally 6 Month reviews get extended due to lack of time to review everything. This show how important of Cystic Fibrosis drug market is.
Given more than 250K price for drug & 4000 patients population (Company likely try make drug available to all 4000 regardless of affordability), We should be generating near $500M+/year in revenue (Assuming 70% paying average 70% of list price) by 2013. off label use & additional approval should make it blockbuster drug selling in multi billion by 2014-2015.
About time where Incivek may see some competition & sale of it might drop below $2B due to that. If we able to keep Incivek selling at current rate about $2B + keep growing on Cystic Fibrosis Market, We will very soon in 50+ range (By end of Q3 atleast).